SCHEMBL9108958

SCHEMBL9108958

CC(C)CC(C(=O)Nc1ccccn1)N1C(=O)C(=O)c2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GCK P35557 2/20 0.53
ALDH1A1 P00352 5/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.45
POLB P06746 1/20 0.45
KDM4E B2RXH2 2/20 0.44
LMNA P02545 1/20 0.44
MMP1 P03956 2/20 0.43
MMP3 P08254 2/20 0.43
MMP9 P14780 2/20 0.43
CDK4 P11802 1/20 0.43
CCND2 P30279 1/20 0.43
SHMT2 P34897 1/20 0.42
AGTR1 P30556 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9108285 0.89 GCK (0.46) GCKALDH1A1RAB9ANPC1USP2
SCHEMBL9104263 0.89 FFAR2 (0.47) GCKALDH1A1MEN1KMT2ANPSR1
SCHEMBL9103795 0.88 FFAR2 (0.46) GCKALDH1A1MEN1KMT2ANPSR1
SCHEMBL9109212 0.88 GCK (0.46) GCKALDH1A1RAB9ANPC1USP2
SCHEMBL1316390 0.88 GCK (0.67) GCKALDH1A1MEN1KMT2ANPSR1
SCHEMBL9106739 0.86 GCK (0.44) GCKALDH1A1MEN1KMT2ANPSR1
SCHEMBL9105927 0.85 GCK (0.45) GCKALDH1A1MEN1KMT2ARAB9A
SCHEMBL9107525 0.83 CHRM5 (0.46) GCKALDH1A1RAB9ANPC1
SCHEMBL9107973 0.82 GCK (0.79) GCKALDH1A1MEN1KMT2ANPSR1
SCHEMBL9106658 0.81 GCK (0.57) GCKALDH1A1MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US claimed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT GCK 488/4885ALDH1A1 646/4885MEN1 2086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.